ADIAL PHARMACEUTICALS, INC. (ADIL) › Net IncomeADIAL PHARMACEUTICALS, INC. (ADIL) — Net IncomeAnnual figures by fiscal year, from SEC filings.2017: -$1.14M2018: -$11.63M2019: -$8.59M2020: -$10.89M2021: -$19.42M2022: -$12.73M2023: -$5.12M2024: -$13.20M2025: -$7.98M-$7.98M2017Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$7.98M+39.6%2024-$13.20M-157.6%2023-$5.12M+59.8%2022-$12.73M+34.5%2021-$19.42M-78.3%2020-$10.89M-26.8%2019-$8.59M+26.1%2018-$11.63M-920.8%2017-$1.14M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share